Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Daniel Kelly

Showing results (51-60 of 140) with videos related to

Pageof 14
Sort By:
JAMA|September 26, 2022
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S VaccinesJ Daniel Kelly, Samuel Leonard, Katherine J Hoggatt, et al.
The American Journal of Tropical Medicine and Hygiene|March 21, 2018
Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional StudyJ Daniel Kelly, Eugene T Richardson, Michael Drasher, et al.
BMJ Global Health|February 10, 2024
Representations of an Ebola 'outbreak' through Story TechnologiesRaphael Frankfurter, Maya Malik, Sahr David Kpakiwa, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resinMiguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, et al.
Annals of Neurology|March 14, 2022
SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19Michael J Peluso, Steven G Deeks, Maja Mustapic, et al.
Plos Neglected Tropical Diseases|August 6, 2019
Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019Lee Worden, Rae Wannier, Nicole A Hoff, et al.
Open Forum Infectious Diseases|December 5, 2022
Social Network Analysis of Ebola Virus Disease During the 2014 Outbreak in Sukudu, Sierra LeoneAshley Hazel, Michelle C Davidson, Abu Rogers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunityJ Daniel Kelly, Katherine J Hoggatt, Nathan C Lo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recencySaki Takahashi, Michael J Peluso, Jill Hakim, et al.
Clinical Trials (London, England)|May 20, 2021
A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemicSalomeh Keyhani, J Daniel Kelly, Stephen Bent, et al.
Pageof 14

Showing results (51-60 of 140) with videos related to

Sort By:
Pageof 14
JAMA|September 26, 2022
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S VaccinesJ Daniel Kelly, Samuel Leonard, Katherine J Hoggatt, et al.
The American Journal of Tropical Medicine and Hygiene|March 21, 2018
Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional StudyJ Daniel Kelly, Eugene T Richardson, Michael Drasher, et al.
BMJ Global Health|February 10, 2024
Representations of an Ebola 'outbreak' through Story TechnologiesRaphael Frankfurter, Maya Malik, Sahr David Kpakiwa, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for <i>Galanthus nivalis</i> agglutinin (GNA) affinity resinMiguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, et al.
Annals of Neurology|March 14, 2022
SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19Michael J Peluso, Steven G Deeks, Maja Mustapic, et al.
Plos Neglected Tropical Diseases|August 6, 2019
Projections of epidemic transmission and estimation of vaccination impact during an ongoing Ebola virus disease outbreak in Northeastern Democratic Republic of Congo, as of Feb. 25, 2019Lee Worden, Rae Wannier, Nicole A Hoff, et al.
Open Forum Infectious Diseases|December 5, 2022
Social Network Analysis of Ebola Virus Disease During the 2014 Outbreak in Sukudu, Sierra LeoneAshley Hazel, Michelle C Davidson, Abu Rogers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2025
Annual variant-targeted vaccination to prevent severe COVID-19 disease in cohorts with vaccine-derived and hybrid immunityJ Daniel Kelly, Katherine J Hoggatt, Nathan C Lo, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recencySaki Takahashi, Michael J Peluso, Jill Hakim, et al.
Clinical Trials (London, England)|May 20, 2021
A telehealth-based randomized controlled trial: A model for outpatient trials of off-label medications during the COVID-19 pandemicSalomeh Keyhani, J Daniel Kelly, Stephen Bent, et al.
Pageof 14